Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Internal Models in Biological Control.

McNamee D, Wolpert DM.

Annu Rev Control Robot Auton Syst. 2019 May 1;2:339-364. doi: 10.1146/annurev-control-060117-105206.

PMID:
31106294
2.

Rapid Visuomotor Responses Reflect Value-Based Decisions.

Carroll TJ, McNamee D, Ingram JN, Wolpert DM.

J Neurosci. 2019 May 15;39(20):3906-3920. doi: 10.1523/JNEUROSCI.1934-18.2019. Epub 2019 Mar 8.

3.

Characterizing the associative content of brain structures involved in habitual and goal-directed actions in humans: a multivariate FMRI study.

McNamee D, Liljeholm M, Zika O, O'Doherty JP.

J Neurosci. 2015 Mar 4;35(9):3764-71. doi: 10.1523/JNEUROSCI.4677-14.2015.

4.

Evidence for model-based computations in the human amygdala during Pavlovian conditioning.

Prévost C, McNamee D, Jessup RK, Bossaerts P, O'Doherty JP.

PLoS Comput Biol. 2013;9(2):e1002918. doi: 10.1371/journal.pcbi.1002918. Epub 2013 Feb 21.

5.

Category-dependent and category-independent goal-value codes in human ventromedial prefrontal cortex.

McNamee D, Rangel A, O'Doherty JP.

Nat Neurosci. 2013 Apr;16(4):479-85. doi: 10.1038/nn.3337. Epub 2013 Feb 17.

6.

The potato: fertile ground for more funding.

Hunt C, McNamee D.

Lancet. 2010 Aug 28;376(9742):669. doi: 10.1016/S0140-6736(10)61318-9. No abstract available.

PMID:
20801390
7.

The response of the human circulatory system to an acute 200-μT, 60-Hz magnetic field exposure.

McNamee DA, Corbacio M, Weller JK, Brown S, Stodilka RZ, Prato FS, Bureau Y, Thomas AW, Legros AG.

Int Arch Occup Environ Health. 2011 Mar;84(3):267-77. doi: 10.1007/s00420-010-0543-1. Epub 2010 May 25.

PMID:
20496180
8.

The cardiovascular response to an acute 1800-microT, 60-Hz magnetic field exposure in humans.

McNamee DA, Corbacio M, Weller JK, Brown S, Prato FS, Thomas AW, Legros AG.

Int Arch Occup Environ Health. 2010 Apr;83(4):441-54. doi: 10.1007/s00420-009-0484-8. Epub 2009 Nov 10.

PMID:
19902234
9.

A literature review: the cardiovascular effects of exposure to extremely low frequency electromagnetic fields.

McNamee DA, Legros AG, Krewski DR, Wisenberg G, Prato FS, Thomas AW.

Int Arch Occup Environ Health. 2009 Aug;82(8):919-33. doi: 10.1007/s00420-009-0404-y. Epub 2009 Feb 17. Review.

PMID:
19221783
10.

Protocol review at The Lancet.

McNamee D, James A, Kleinert S.

Lancet. 2008 Jul 19;372(9634):189-90. doi: 10.1016/S0140-6736(08)61053-3. No abstract available.

PMID:
18640443
11.

Roles of integrin activation in eosinophil function and the eosinophilic inflammation of asthma.

Barthel SR, Johansson MW, McNamee DM, Mosher DF.

J Leukoc Biol. 2008 Jan;83(1):1-12. Epub 2007 Oct 10. Review.

12.

Apostrophe catastrophe.

McNamee D.

Lancet. 2006 Nov 11;368(9548):1636. No abstract available.

PMID:
17098068
13.

What's maths got to do with it?

McNamee D.

Lancet. 2005 Jul 9-15;366(9480):108. No abstract available.

PMID:
16005319
14.

Nestlé's own goal.

McNamee D.

Lancet. 2003 Jan 4;361(9351):12. No abstract available.

PMID:
12517457
15.

Spinal anaesthesia: comparison of plain ropivacaine 5 mg ml(-1) with bupivacaine 5 mg ml(-1) for major orthopaedic surgery.

McNamee DA, McClelland AM, Scott S, Milligan KR, Westman L, Gustafsson U.

Br J Anaesth. 2002 Nov;89(5):702-6.

16.

Rapid reviews in The Lancet--and beyond.

James A, McNamee D, Horton R.

Lancet. 2002 Jul 13;360(9327):102. No abstract available.

PMID:
12126817
17.

Peer review in a small and a big medical journal: case study of the Croatian Medical Journal and the Lancet.

Marusić A, Lukić IK, Marusić M, McNamee D, Sharp D, Horton R.

Croat Med J. 2002 Jun;43(3):286-9.

19.

Intrathecal ropivacaine for total hip arthroplasty: double-blind comparative study with isobaric 7.5 mg ml(-1) and 10 mg ml(-1) solutions.

McNamee DA, Parks L, McClelland AM, Scott S, Milligan KR, Ahlén K, Gustafsson U.

Br J Anaesth. 2001 Nov;87(5):743-7.

20.

Shameful UK government loan to Tanzania.

McNamee D.

Lancet. 2002 Jan 5;359(9300):8. No abstract available.

PMID:
11809179
21.

New drug classes 2001.

McNamee D, Sharp D.

Lancet. 2001 Nov 3;358(9292):1478. No abstract available.

PMID:
11705558
22.

Tackling venomous snake bites worldwide.

McNamee D.

Lancet. 2001 May 26;357(9269):1680. No abstract available.

PMID:
11425384
23.

Review of clinical protocols at The Lancet.

McNamee D.

Lancet. 2001 Jun 9;357(9271):1819-20. No abstract available.

PMID:
11410187
24.

Cancer paper retracted.

McNamee D.

Lancet. 2001 Apr 28;357(9265):1343. No abstract available.

PMID:
11343749
25.

Total knee replacement: a comparison of ropivacaine and bupivacaine in combined femoral and sciatic block.

McNamee DA, Convery PN, Milligan KR.

Acta Anaesthesiol Scand. 2001 Apr;45(4):477-81.

PMID:
11300387
26.

Pies flying low in a blue sky.

McNamee D.

Lancet. 2000 Dec 9;356(9246):1948. No abstract available.

PMID:
11130521
27.

Ovarian-cancer results cause a stir at cancer conference.

McNamee D.

Lancet. 2000 May 27;355(9218):1890. No abstract available.

PMID:
10866453
28.

Pharmacovigilance into 2000.

McNamee D.

Lancet. 1999 Oct 23;354(9188):1406. No abstract available.

PMID:
10543665
29.

Anaesthesia for caesarean section in the presence of severe primary pulmonary hypertension.

O'Hare R, McLoughlin C, Milligan K, McNamee D, Sidhu H.

Br J Anaesth. 1998 Nov;81(5):790-2.

30.

Experts clash over cancer mortality at WHO meeting.

McNamee D.

Lancet. 1998 Oct 24;352(9137):1361. No abstract available.

PMID:
9802284
31.

Consensus reached at new European breast-cancer meeting.

McNamee D.

Lancet. 1998 Oct 10;352(9135):1200. No abstract available. Erratum in: Lancet 1998 Oct 17;352(9126):1316.

PMID:
9777848
32.

Cancer hopes and setbacks.

McNamee D.

Lancet. 1998 May 16;351(9114):1450. No abstract available.

PMID:
9605800
33.

Public's perception of RCTs.

McNamee D.

Lancet. 1998 Mar 14;351(9105):772. No abstract available.

PMID:
9519947
34.

Fast-track publication at The Lancet.

McNamee D.

Lancet. 1998 Feb 21;351(9102):542. No abstract available.

PMID:
9492771
35.

Communicating drug-safety information.

McNamee D.

Lancet. 1997 Dec 6;350(9092):1646. No abstract available.

PMID:
9400507
36.

Fast-track to publication in the Lancet.

McNamee D, Horton R.

Lancet. 1997 Apr 5;349(9057):970. No abstract available.

PMID:
9132517
37.

"Euro-oncocredit" moves nearer.

McNamee D.

Lancet. 1997 Feb 15;349(9050):448. No abstract available.

PMID:
9040572
38.

Different kind of drug-company freebie.

McNamee D.

Lancet. 1996 Oct 19;348(9034):1048. No abstract available.

PMID:
8874454
39.

Speaking about pharmacovigilance.

McNamee D.

Lancet. 1996 Oct 5;348(9032):908. No abstract available.

PMID:
8843807
40.

Lies, damn lies, and reports of RCTs.

McNamee D, Horton R.

Lancet. 1996 Aug 31;348(9027):562. No abstract available.

PMID:
8774566
41.

Living with HUGO.

McNamee D.

Lancet. 1995 Aug 19;346(8973):497. No abstract available.

PMID:
7637489
42.

Beta-hCG inhibits Kaposi's sarcoma.

McNamee D.

Lancet. 1995 May 6;345(8958):1169. No abstract available.

PMID:
7536873
43.

Taxol's pedigree.

McNamee D.

Lancet. 1995 Mar 25;345(8952):743. No abstract available.

PMID:
7891481
44.

UICC cancer olympiad in New Delhi.

McNamee D.

Lancet. 1994 Nov 12;344(8933):1357. No abstract available.

PMID:
7968036
45.

Free radicals: trick or treat?

McNamee D.

Lancet. 1994 Sep 10;344(8924):702. No abstract available.

PMID:
7915772
46.

Normal and abnormal haemopoiesis.

McNamee D.

Lancet. 1994 Jul 16;344(8916):185-6. No abstract available.

PMID:
7912775
47.

Over-the-counter over Europe.

McNamee D.

Lancet. 1994 Jun 25;343(8913):1629. No abstract available.

PMID:
7911930
48.

Working to survive.

McNamee D.

Lancet. 1994 Apr 16;343(8903):930. No abstract available.

PMID:
7909005
49.

Clinical oncology.

McNamee D.

Lancet. 1993 Nov 27;342(8883):1357. No abstract available.

PMID:
7901644
50.

Health costs.

McNamee D.

Lancet. 1993 Jul 10;342(8863):105-6. No abstract available.

PMID:
8100867

Supplemental Content

Loading ...
Support Center